(Q34476950)

2 August 2017

1 reference

title

Nonmyeloablative transplantation in children. Current status and future prospects (English)

1 reference

2 August 2017

M A Pulsipher

1

1 reference

PubMed ID

11765375

2 August 2017

A Woolfrey

series ordinal

2

1 reference

2 August 2017

1 October 2001

1 reference

Hematology / Oncology Clinics of North America

2 August 2017

1 reference

2 August 2017

15

1 reference

2 August 2017

5

1 reference

2 August 2017

809-34, vii-viii

1 reference

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Adoptive immunotherapy in canine chimeras.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Bone marrow transplantation for hemoglobinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

HLA-A2402-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of a child with Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Allogeneic haematopoietic transplantation for Richter's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Mixed chimerism as an approach to transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Immunologic tolerance to renal allografts after bone marrow transplants from the same donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970253-7

7 January 2021

10.1016/S0889-8588(05)70253-7

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11765375